The short answer
Phenelzine has been associated with vitamin B6 deficiency in a few case reports. Adequate dietary intake and assessment when concerning symptoms occur are reasonable topics for your prescriber. The evidence does not establish that every person taking phenelzine needs a B6 supplement or routine testing.
What this answer covers
Vitamin B6 status during oral phenelzine treatment. The reported corrective treatment was pyridoxine; other B6 forms and preventive regimens are not assumed to have equivalent evidence.
- Supplement or preparation
- Vitamin B6
- Medication ingredient
- phenelzine
What the reports found
Two young men developed low vitamin B6 while receiving phenelzine, and their laboratory levels and possibly related symptoms improved after pyridoxine. A separate report described deficiency and nerve symptoms during long-term treatment.
When to bring it up
Discuss persistent or unexplained symptoms, especially new numbness, tingling or balance problems, with the clinician managing treatment. Such symptoms have several possible causes and should not be assumed to prove a B6 deficiency.
A supplement is not automatically required
The reports support adequate intake and considering deficiency when problems arise. They do not demonstrate that everyone needs a pill, a particular laboratory schedule or a preventive dose. A clinician can decide whether testing or replacement is appropriate.
Too much B6 can also injure nerves
High supplemental pyridoxine can cause neuropathy. Avoid treating new nerve symptoms by escalating a B-complex or B6 product yourself. Bring all supplement labels so the clinician can see the total intake.
Evidence and practical considerations
Timing & monitoring
Case reports describe low B6 during phenelzine therapy, with improvement after pyridoxine in two patients and a separate report of deficiency-associated neuropathy. These support clinical consideration, not universal prophylaxis.
- Exact scope
- Vitamin B6 status during oral phenelzine treatment. The reported corrective treatment was pyridoxine; other B6 forms and preventive regimens are not assumed to have equivalent evidence. with Oral phenelzine tablets; current sulfate-tablet labeling uses the named active ingredient.
- Medication form and route
- oral
What remains uncertain
- Small uncontrolled reports; no rate, screening interval, universal dose or controlled prevention benefit established. Excessive pyridoxine can itself cause neuropathy.
Factors that may matter: Exact supplement preparation and complete concomitant-medication list require assessment..
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral phenelzine sulfate tablets.
The label prohibits sympathomimetics, L-tryptophan, L-tyrosine, phenylalanine and serotonergic agents. It warns about excessive caffeine and high-tyramine exposures.
How this applies: Primary authority for phenelzine oral-tablet precautions; each article identifies whether the supplement is named or the application is a constituent/class inference.
Regulatory instructions do not quantify an exact-pair event rate or validate every botanical formulation.
Source 2: Human case reports
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two young men treated with phenelzine.
Low B6 levels and possibly related symptoms improved after pyridoxine was supplied; authors advised adequate dietary intake and considering deficiency when problems arise.
How this applies: Two uncontrolled cases. No universal testing interval, preventive dose or demonstration that every phenelzine user needs a supplement.
Two uncontrolled cases. No universal testing interval, preventive dose or demonstration that every phenelzine user needs a supplement.
Source 3: Human case report
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One 51-year-old nonalcoholic, nondiabetic woman.
Sensorimotor peripheral neuropathy occurred alongside pyridoxine deficiency; the authors proposed a possible pyridoxine-responsive association.
How this applies: Single uncontrolled report. Alternative causes, incidence and optimal management cannot be established from the abstract.
Single uncontrolled report. Alternative causes, incidence and optimal management cannot be established from the abstract.
Source 4: Federal nutrient safety information
ods.od.nih.gov · Source check Sep 10, 2026
Population: General populations using pyridoxine supplements.
Excessive pyridoxine can itself cause peripheral sensory neuropathy.
How this applies: Not a phenelzine trial. Does not define a phenelzine-specific supplementation regimen; national upper intake limits differ.
Not a phenelzine trial. Does not define a phenelzine-specific supplementation regimen; national upper intake limits differ.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial targeted research draft. Inspected source material, adjudicated the current checker statements, and recorded preparation limits. Clinical review has not occurred. | |
| Research summary published |
Article revision: d7cc7066e7ac5d3f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.